Helicobacter pylori (H. pylori) infection is highly associated with the occurrence of
gastrointestinal diseases, including gastric inflammation, peptic ulcer, gastric cancer, and …

Helicobacter pylori (H. pylori) is an important major cause of peptic ulcer disease and gastric
malignancies such as mucosa-associated lymphoid tissue lymphoma and gastric …

Helicobacter pylori (H. pylori) is a well-known human pathogen that plays an essential role
in the pathogenesis of chronic gastritis, peptic ulcer disease, and gastric malignancies …

Helicobacter pylori (H. pylori) is a major human pathogen associated with significant
morbidity and mortality. However, after decades of efforts, treatment of H. pylori remains a …

Triple therapy, consisting of two antibiotics, clarithomycin and amoxicillin or metronidazole in
combination with a proton pump inhibitor (PPI) has become the first-line option for infection …

Helicobacter pylori (HP) is a major causative agent of chronic gastritis and peptic ulcer. HP
is also engaged in the development of gastric cancer and gastric mucosa-associated …

Although Helicobacter pylori infection is both a common and a serious bacterial infection,
antimicrobial therapies have rarely been optimized, are prescribed empirically, and provide …

Helicobacter pylori (H. pylori) plays a crucial role in the pathogenesis of chronic active
gastritis, peptic ulcer and gastric mucosa-associated lymphoid tissue-lymphoma, and is also …

Indroduction: Treatment of Helicobacter pylori (H. pylori) infection is crucial for prevalent
disease's management, including gastritis, peptic ulcer and gastric cancer, whereas novel …

Since the discovery of Helicobacter pylori in the early 1980s many treatment regimes have
been developed to effectively treat this infection. International guidelines have allowed …